Caroline A. LibbyAssociateProskauer Rose LLPWebsitewww.proskauer.comOrganization ProfileFull ProfileConnectEmail212.969.3174 Professional Biography Caroline Libby is an associate in the Labor & Employment Department and a member of the Employment Litigation & Arbitration Group. More Legal and Business Bylines From Caroline A. Libby AI-Based Discrimination Top of the EEOC’s Draft Enforcement Plan - (Posted On Tuesday, January 17, 2023) SCOTUS Denies Review and Leaves Seattle’s “Play-or Pay” Ordinance Intact - (Posted On Wednesday, November 30, 2022) D.C. Paid Leave Law Changes Go Into Effect October 1, 2022 - (Posted On Friday, September 16, 2022) General Counsel Abruzzo Looks to Overturn Board Precedent Again: This Time, Seeking to Broaden Union Access to Public Spaces - (Posted On Tuesday, May 31, 2022) Current Legal Analysis Scrutiny on Financial Institutions Compliance Expected to Increase During Trump Administration by: Mark D. Nelson President Trump’s Executive Orders on Immigration and What They Mean for Employers by: Otieno B. Ombok , Amy L. Peck US Treasury and IRS Unveil Proposed Regulations for Commercial EV Tax Credit, Sparking Questions on Recapture Provisions by: Chris DiAngelo , Brandon D. Hadley At Long Last, DEA’s Remote Prescribing Rules 2.0 Are (Really) Here! (Pending Further Consideration by the Incoming Administration . . .) by: Alan J. Arville , Audrey Davis The TikTok Ban Saga: SCOTUS, Trump’s Executive Order, and the Implications for Digital Marketing and Emerging Platforms by: Jeffrey M. Kelly FTC Announces Significant Increases to the 2025 HSR Reporting Thresholds by: Carrie A. Hanger , Colleen Pleasant Kline New TTB Standard of Fill No Place for Kegged Cocktails by: Benjamin Sheppard 60-Second Sustains: The Mission Essential Group by: Elizabeth N. Jochum , David L. Bodner Upcoming Events Jan 22 2025 Employee Activism and the Issues It Can Create Jan 22 2025 The SEC under President Trump: A Preview Jan 22 2025 Transgender Employees and Related Issues in the Workplace Jan 28 2025 Antibody Drug Conjugates Keep Growing: What You Need to Know Print
